CVE:OGI - OrganiGram Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started C$4.89 -0.08 (-1.61 %) (As of 12/13/2018 03:55 AM ET)Previous CloseC$4.97Today's RangeC$4.83 - C$5.1652-Week RangeC$3.26 - C$8.55Volume586,176 shsAverage Volume1.37 million shsMarket CapitalizationN/AP/E Ratio1,628.33Dividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email OrganiGram Holdings Inc., through its subsidiaries, produces and sells medical marijuana to individuals and physicians in Canada. It offers marijuana plants, seeds, and cuttings; cannabis oil; and dried flower and cannabis. The company sells its products through phone and online store. It also operates healing centers that offer treatments for post-traumatic stress disorders, chronic pain, and trauma therapy. In addition, the company exports its products. OrganiGram Holdings Inc. was founded in 2013 and is based in Moncton, Canada. Receive OGI News and Ratings via Email Sign-up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange CVE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryCannabis SectorMedical Current SymbolCVE:OGI Previous Symbol CUSIPN/A Webwww.organigram.ca PhoneN/A Debt Debt-to-Equity Ratio59.90 Current Ratio20.63 Quick Ratio17.52 Price-To-Earnings Trailing P/E Ratio1,628.33 Forward P/E Ratio37.43 P/E GrowthN/A Sales & Book Value Annual SalesC$12.25 million Price / Sales49.95 Cash FlowC$1.21 per share Price / Cash Flow4.04 Book ValueC$1.32 per share Price / Book3.70 Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous Employees261 Outstanding Shares125,243,000Market CapC$0.00 OptionableNot Optionable OrganiGram (CVE:OGI) Frequently Asked Questions What is OrganiGram's stock symbol? OrganiGram trades on the Canadian Venture Exchange (CVE) under the ticker symbol "OGI." When is OrganiGram's next earnings date? OrganiGram is scheduled to release their next quarterly earnings announcement on Monday, February 4th 2019. View Earnings Estimates for OrganiGram. What price target have analysts set for OGI? 1 analysts have issued 1-year price objectives for OrganiGram's shares. Their forecasts range from C$5.50 to C$12.00. On average, they expect OrganiGram's share price to reach C$8.17 in the next year. This suggests a possible upside of 67.2% from the stock's current price. View Analyst Price Targets for OrganiGram. What is the consensus analysts' recommendation for OrganiGram? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for OrganiGram. Has OrganiGram been receiving favorable news coverage? Headlines about OGI stock have trended neutral recently, according to InfoTrie. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. OrganiGram earned a coverage optimism score of 0.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an effect on the company's share price in the next several days. Who are some of OrganiGram's key competitors? Some companies that are related to OrganiGram include Acerus Pharmaceuticals (ASP), Aequus Pharmaceuticals (AQS), Amryt Pharma (AMYT), Aphria (APH), Aurora Cannabis (ACB), Bausch Health Companies (BHC), Benchmark (BMK), Biosyent (RX), Cannabis Science (CBIS), Canopy Growth (WEED), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF), Cipher Pharmaceuticals (CPH) and Cosmos (COSM). Who are OrganiGram's key executives? OrganiGram's management team includes the folowing people: Mr. Greg Engel, CEO & Director (Age 53)Mr. Raymond Gracewood, Chief Commercial OfficerMr. Larry Rogers, VP of International Bus. Devel.Mr. Peter R. Hanson, Director of Fin.Mr. Paolo De Luca C.A., C.F.A, Chief Financial Officer (Age 45) How do I buy shares of OrganiGram? Shares of OGI and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is OrganiGram's stock price today? One share of OGI stock can currently be purchased for approximately C$4.89. What is OrganiGram's official website? The official website for OrganiGram is http://www.organigram.ca. MarketBeat Community Rating for OrganiGram (CVE OGI)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 187 (Vote Outperform)Underperform Votes: 154 (Vote Underperform)Total Votes: 341MarketBeat's community ratings are surveys of what our community members think about OrganiGram and other stocks. Vote "Outperform" if you believe OGI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OGI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/13/2018 by MarketBeat.com StaffFeatured Article: What is an investor looking for in an SEC filing?